These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34839360)

  • 1. Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography.
    Smart K; Yttredahl A; Oquendo MA; Mann JJ; Hillmer AT; Carson RE; Miller JM
    Transl Psychiatry; 2021 Nov; 11(1):602. PubMed ID: 34839360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa opioid receptor binding in major depression: A pilot study.
    Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
    Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.
    Pietrzak RH; Naganawa M; Huang Y; Corsi-Travali S; Zheng MQ; Stein MB; Henry S; Lim K; Ropchan J; Lin SF; Carson RE; Neumeister A
    JAMA Psychiatry; 2014 Nov; 71(11):1262-1271. PubMed ID: 25229257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroanatomic correlates of psychopathologic components of major depressive disorder.
    Milak MS; Parsey RV; Keilp J; Oquendo MA; Malone KM; Mann JJ
    Arch Gen Psychiatry; 2005 Apr; 62(4):397-408. PubMed ID: 15809407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers.
    Matuskey D; Dias M; Naganawa M; Pittman B; Henry S; Li S; Gao H; Ropchan J; Nabulsi N; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1714-1719. PubMed ID: 30928993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
    Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
    Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofrontality and negative symptoms in major depressive disorder.
    Galynker II; Cai J; Ongseng F; Finestone H; Dutta E; Serseni D
    J Nucl Med; 1998 Apr; 39(4):608-12. PubMed ID: 9544664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
    Martinez D; Slifstein M; Matuskey D; Nabulsi N; Zheng MQ; Lin SF; Ropchan J; Urban N; Grassetti A; Chang D; Salling M; Foltin R; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1720-1727. PubMed ID: 31026862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations Among mRNA Expression Levels of ATP7A, Serum Ceruloplasmin Levels, and Neuronal Metabolism in Unmedicated Major Depressive Disorder.
    Liu X; Zhong S; Yan L; Zhao H; Wang Y; Hu Y; Jia Y
    Int J Neuropsychopharmacol; 2020 Dec; 23(10):642-652. PubMed ID: 32427278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting-state functional connectivity of the anterior cingulate cortex in young adults depressed patients with and without suicidal behavior.
    Qiu H; Cao B; Cao J; Li X; Chen J; Wang W; Lv Z; Zhang S; Fang W; Ai M; Kuang L
    Behav Brain Res; 2020 Apr; 384():112544. PubMed ID: 32035184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia.
    Slifstein M; Qu W; Gil R; Weinstein JJ; Perlman G; Jaworski-Calara T; Meng J; Hu B; Moeller SJ; Horga G; Abi-Dargham A
    Neuropsychopharmacology; 2024 Dec; 49(13):2087-2093. PubMed ID: 39217267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting regional brain activity correlates of verbal learning deficit in major depressive disorder.
    Milak MS; Potter WA; Pantazatos SP; Keilp JG; Zanderigo F; Schain M; Sublette ME; Oquendo MA; Malone KM; Brandenburg H; Parsey RV; Mann JJ
    Psychiatry Res Neuroimaging; 2019 Jan; 283():96-103. PubMed ID: 30580237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.
    Cannon DM; Carson RE; Nugent AC; Eckelman WC; Kiesewetter DO; Williams J; Rollis D; Drevets M; Gandhi S; Solorio G; Drevets WC
    Arch Gen Psychiatry; 2006 Jul; 63(7):741-7. PubMed ID: 16818863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder.
    Tiger M; Farde L; Rück C; Varrone A; Forsberg A; Lindefors N; Halldin C; Lundberg J
    Psychiatry Res Neuroimaging; 2016 Jul; 253():36-42. PubMed ID: 27269199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression.
    Reivich M; Amsterdam JD; Brunswick DJ; Shiue CY
    J Affect Disord; 2004 Oct; 82(2):321-7. PubMed ID: 15488265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.
    Kolla NJ; Chiuccariello L; Wilson AA; Houle S; Links P; Bagby RM; McMain S; Kellow C; Patel J; Rekkas PV; Pasricha S; Meyer JH
    Biol Psychiatry; 2016 Jan; 79(2):117-26. PubMed ID: 25698585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.
    Cannon DM; Klaver JM; Peck SA; Rallis-Voak D; Erickson K; Drevets WC
    Neuropsychopharmacology; 2009 Apr; 34(5):1277-87. PubMed ID: 18946469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age.
    Vijay A; Cavallo D; Goldberg A; de Laat B; Nabulsi N; Huang Y; Krishnan-Sarin S; Morris ED
    Neuropsychopharmacology; 2018 Dec; 43(13):2539-2547. PubMed ID: 30188515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder.
    Attwells S; Setiawan E; Rusjan PM; Xu C; Hutton C; Rafiei D; Varughese B; Kahn A; Kish SJ; Vasdev N; Houle S; Meyer JH
    Biol Psychiatry; 2020 Oct; 88(8):649-656. PubMed ID: 32402468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.